Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP382541.RABZfsPx9_B3aR6yZVOs1kNzAaiTpFdMPyuJHdbDG_s_g130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382541.RABZfsPx9_B3aR6yZVOs1kNzAaiTpFdMPyuJHdbDG_s_g130_provenance.
• NP880169.RAXTpaT5Ul4f5IPnnHYh6W7sig7LWwjbZQeaXDhaceqt8130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880169.RAXTpaT5Ul4f5IPnnHYh6W7sig7LWwjbZQeaXDhaceqt8130_provenance.
• NP557288.RAukHnALBqLYV8e0UOuzSVaVt2_PK5QZ24kzDLhWPB4NE130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557288.RAukHnALBqLYV8e0UOuzSVaVt2_PK5QZ24kzDLhWPB4NE130_provenance.
• NP414323.RAq_c1wBhJLy9vPY7XRSOtGkDLu0nx7LKPW5uG_cPmvTQ130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414323.RAq_c1wBhJLy9vPY7XRSOtGkDLu0nx7LKPW5uG_cPmvTQ130_provenance.
• NP794059.RAZePTVG0YKi_-5WiiTf9VOMUm49UMIrMx4Dy5YOQ16eI130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794059.RAZePTVG0YKi_-5WiiTf9VOMUm49UMIrMx4Dy5YOQ16eI130_provenance.
• NP343198.RA41itODU8Py6CZsHaRpOBVoz6bz5eAyHRRhHPA-zCUk8130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343198.RA41itODU8Py6CZsHaRpOBVoz6bz5eAyHRRhHPA-zCUk8130_provenance.
• NP902171.RAuAyMoz-qN4WRZ4MNWUisjeTfbnL258QgrIAoG5iNH9s130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902171.RAuAyMoz-qN4WRZ4MNWUisjeTfbnL258QgrIAoG5iNH9s130_provenance.
• NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_provenance.
• NP808097.RAn7Zr6PV9UNbwK8SE6b8vcDxhETP3PqDvyoZbWUUaKJ0130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808097.RAn7Zr6PV9UNbwK8SE6b8vcDxhETP3PqDvyoZbWUUaKJ0130_provenance.
• NP813404.RAlQxO5b5b-WwM3fzGsXiZer7U53N8bxGKKGgLQJ_XD08130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP813404.RAlQxO5b5b-WwM3fzGsXiZer7U53N8bxGKKGgLQJ_XD08130_provenance.
• NP168618.RAIyzAHl5rSWEdFr_qCbTBKn5w_3DF3DYkYLqQyJTLy7c130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168618.RAIyzAHl5rSWEdFr_qCbTBKn5w_3DF3DYkYLqQyJTLy7c130_provenance.
• NP660973.RA-1XJ7Rg_Frfc1TkVqBA86_iNJ6Q7GY72BZQItVWv17E130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660973.RA-1XJ7Rg_Frfc1TkVqBA86_iNJ6Q7GY72BZQItVWv17E130_provenance.
• NP810718.RAEM694YU8Ps-usOnZ8UfNsJ1b_nG_1K_julU4jLrQzes130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810718.RAEM694YU8Ps-usOnZ8UfNsJ1b_nG_1K_julU4jLrQzes130_provenance.